Completed Genetics & Molecular Biology Cancer

Cell cycle regulated transcription and control of genome integrity

In plain English

AI plain-English summary

Every time a cell divides, it must first pass through a molecular gate called G1-phase—and when that gate breaks, cells can start multiplying uncontrollably, forming tumours. This research tackles a fundamental gap in cancer biology: how DNA damage checkpoints, which normally halt cell division when genetic material is faulty, interact with the proteins that control the G1-phase exit. Many of those G1-S control proteins are found mutated in human cancers, suggesting that disabling this pathway helps tumours develop. The researcher has already shown that the G1-S transcriptional network is a target of DNA structure checkpoints. Now they aim to map the precise biochemical interplay between these two systems. This is fundamental science with no immediate clinical application. However, understanding how cells coordinate division with genome surveillance could eventually reveal new drug targets. If researchers can pinpoint how checkpoint failures allow damaged cells to slip through G1-S, they may identify molecular levers to restore that brake. Past work on cell-cycle checkpoints has already produced cancer therapies—such as drugs that exploit checkpoint defects in tumour cells—so a deeper mechanistic picture here could feed into that pipeline.

View original technical description
Cancer is a group of diseases in which cells continue to multiply in an unregulated manner. The main regulation of initiation of a new cell division cycle is imposed during a specific phase of the cell cycle called G1. Proteins that control exit from G1-phase, including those involved in regulating G1-S transcription, are often found mutated in human tumour cells, suggesting that inactivation of this pathway may be necessary for tumour development. DNA structure checkpoints restrict cell-cycle progression in response to the detection of abnormalities in the genetic material. When these checkpoints fail, cells are at risk of increased genetic abnormalities, phenomena that are associated with tumour development. My previous work showed that the G1-S transcriptional regulatory network is a target of DNA structure checkpoints. The goal of my future research programme is to build on this work to understand the interplay between the DNA structure checkpoints and the regulation of G1-S transcription. To do this, I will employ a combination of biochemical and molecular biological techniques. I believe that understanding the mechanisms governing regulation of G1-S transcription in response to genotoxic stress and during the cell-cycle will provide new insights into the genesis and treatment of human cancer.

View the original record at the funder ↗

Researchers

Robertus De Bruin (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Transcriptional control of gene expression during the G2-M phase of the cell cycle
Mechanistic insights into the periodic control of transcription in the mammalian cell cycle
Regulation of Initiation of DNA replication
Chromosomal Instability in Cancer Pathogenesis and Treatment (MRC Programme 1)
The E2F pathway: new levels of control and regulation

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.